JuveLook (1x50mg)
The lowest price of the product zł719.00 in day 31.01.2026
Lowest price in the last 30 days: zł719.00
JuveLook is a sterile, biocompatible Class III medical device in the form of a lyophilisate for suspension, consisting of a hybrid of Poly-D,L-Lactic Acid (PDLLA) and non-cross-linked sodium hyaluronate. It is the only polylactic acid preparation with physicochemical parameters that allow for safe application in the delicate periocular area. The device acts as a biomechanical stimulator of the extracellular matrix, providing immediate hydration and long-term restructuring of soft tissues.
mechanism of action
-
induction of neocollagenesis (pdlla): poly-d,l-lactic acid microparticles (10-40 μm) with a regular, spherical shape activate fibroblasts to synthesize collagen and elastin, leading to physical skin densification and improvement of mechanical parameters
-
hydrodynamic stabilization (ha): high-molecular-weight non-cross-linked hyaluronic acid (3000 kDa) ensures immediate water retention and a filling effect directly after implantation
-
biomechanical tissue restructuring: the collagen stimulation process occurs gradually, replacing the volume of the preparation with a newly formed network of structural fibers, which prevents lump formation and eliminates the need for post-treatment massage
-
optimization of the ecm microenvironment: the combination of ha and pdlla improves skin structure and texture, supporting its regeneration and physiological tension
-
neutralization of photoaging effects: through the structural restoration of the dermal layers, the device reduces the visibility of fine lines and restores tissue cohesion
indications and intended use
The device is intended for intradermal and subcutaneous implantation by authorized medical personnel for:
-
revitalization of the periocular area: correction of the tear trough, lower eyelid, and "crow's feet"
-
biostimulation and skin densification: improvement of the structure of the face, forehead, neck, and décolletage
-
filling of depressions and volume deficits: restoring the biomechanical integrity of soft tissues
-
deep hydration and improvement of skin tone: physical improvement of texture in skin requiring intensive regeneration
application areas
-
eye area (eyelids, tear trough)
-
face (forehead, cheeks)
-
neck and décolletage
composition
-
Poly-D,L-Lactic Acid (PDLLA): 42.5 mg (particles 10-40 μm)
-
Non-cross-linked Sodium Hyaluronate: 7.5 mg (molecular weight 3000 kDa)
technical information
-
form: lyophilized powder in a 50 mg vial
-
preparation: dissolve in 8 ml of saline for injection; homogenization process using a Vortex shaker (cycles: 3 min spinning / 5 min rest / 3 min spinning)
-
application site: dermis or subcutaneous tissue
-
treatment cycle: 2-3 sessions at 6-8 week intervals are recommended; a touch-up treatment after 24 months
-
duration of effect: collagen production begins after approx. 2 weeks; clinical effects last over 24 months from the end of the series
contents
-
1 vial containing 50 mg of lyophilisate
|
VIAL |
||
|
The product may only be used by professionals. By making a purchase, you declare that you are a doctor or cosmetologist trained in aesthetic medicine. |
||